Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer.
Jahid S, Ortega JA, Vuong LM, Acquistapace IM, Hachey SJ, Flesher JL, La Serra MA, Brindani N, La Sala G, Manigrasso J, Arencibia JM, Bertozzi SM, Summa M, Bertorelli R, Armirotti A, Jin R, Liu Z, Chen CF, Edwards R, Hughes CCW, De Vivo M, Ganesan AK.
Jahid S, et al. Among authors: ortega ja.
Cell Rep. 2022 Apr 26;39(4):110760. doi: 10.1016/j.celrep.2022.110760.
Cell Rep. 2022.
PMID: 35476990
Free PMC article.
No abstract available.